Celif | Characters

Celif by Fluffsamasprime
Available
 Title: Best Antagonist 2021, Best New Character 2021
 Gender: Male
 Height: 6'2
 Created: December 27th, 2020
Quality 
6.5
Creativity 
6.7
Entertainment 
6.9
Design sheet

Latest Comics


View Celif's full Comic Archive

Biography

Age: 22
Height: 6’2

Celif is an albino griffin who does a lot more self medicating than what is good for him.
He specializes in small time drug manufacturing and distribution. Moving to void to get a new client base and improve his skills. Taking up residence near Void City Labs for easier access to chemicals, and other useful things.
He has a habit of plucking his feathers on the side of his head when he’s stressed, and coughing fits when he over-exerts himself.

Celif spends most his time in his human form, since it's easier for him to slip into crowds. Keeping his griffin form more of a secret unless he has to make an abrupt get away.
Transformation is similar to werewolves where feathers cover his body and clothes when he changes.

-Hollow bones are easier to break and make him lighter weight.
-Paints his nails black
-Shady dealings includes organ harvesting
-Often has nose bleeds

Scar History:
-Lilyfeather used necromancy to kill the fingers on his left hand.

Latest Topics -

 
All News, All The Time 
Last updated: Staff Bot - Feb 29, 2024, 02:53 AM
Clown Jam 
Last updated: Radji - Feb 11, 2024, 04:51 AM
INTRODUCE YOURSELF 
Last updated: Maz - Nov 06, 2023, 04:13 PM
FAQ: Questions About Void? Post Yours Here! 
Last updated: Darius Corry - Sep 09, 2023, 03:15 PM
Art Diary of an Eternal Student 
Last updated: BoogidiBzdo - Aug 22, 2023, 09:17 PM
 

Latest Members -


Users online -

 
51 Guests, 0 Users


Most Online Today: 60.
Most Online Ever: 1,184 (Jan 13, 2020, 06:21 PM)

 

About Us

We exist to provide an environment for artists to learn and improve their sequential art skills competitively. Our community is designed to give critical feedback and encouragement to our many members the world over, at all skill levels.

Follow Us